Mastodon

Baryta carbonica (Granules) Instructions for Use

Marketing Authorization Holder

Boiron (France)

Contact Information

BOIRON (France)

ATC Code

V30 (Not assigned)

Dosage Forms

Bottle OTC Icon Baryta carbonica Homeopathic granules C5: 4 g tube with granule counter
Homeopathic granules C9: 4 g tube with granule counter
Homeopathic granules C15: 4 g tube with granule counter
Homeopathic granules C30: 4 g tube with granule counter

Dosage Form, Packaging, and Product Composition

Homeopathic granules Potency
Baryta carbonica (Baryta carbonica) C5
Homeopathic granules Potency
Baryta carbonica (Baryta carbonica) C9
Homeopathic granules Potency
Baryta carbonica (Baryta carbonica) C15
Homeopathic granules Potency
Baryta carbonica (Baryta carbonica) C30

Excipients : sucrose, lactose.

4 g – tubes with granule counter (1) – cardboard packs.

Clinical-Pharmacological Group

Single-component homeopathic preparation of mineral-chemical origin

Pharmacotherapeutic Group

Homeopathic agent

Pharmacological Action

Barium carbonate is used in measured doses in conventional medicine drugs.

It has a hypotensive effect on arterial circulation caused by vascular atherosclerosis.

It acts on sclerotic degeneration of connective tissue.

Indications

Key symptoms for prescribing the drug

  • Mental, nervous, and physical weakness;
  • Chronic hypertrophy of the tonsils with frequent inflammation;
  • Tendency to suppuration of ENT organs, causing difficulty swallowing and accompanied by bulky submandibular and cervical lymphadenopathy;
  • Delayed psychomotor development;
  • Delayed puberty.

Main cases of clinical application

Otorhinolaryngology

  • Hypertrophied tonsils, prevention of recurrent tonsillitis.

Behavioral disorders

  • Delayed physical and especially mental development; problems with learning school subjects.

Disorders related to aging

  • Hypertension caused by arteriosclerosis (in addition to prescribed allopathic treatment);
  • Prevention of pathological aging;
  • Pulmonary sclerosis (pneumosclerosis) and chronic bronchitis in the elderly;
  • Motor and intellectual consequences of strokes;
  • Prostate adenoma.

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Sublingually.

The granules should be dissolved in the mouth 30 minutes before a meal or 60 minutes after a meal.

For children from 0 to 3 years old, the granules are first diluted by shaking in 10-15 ml of water at room temperature and given to drink 30 minutes before a meal or 60 minutes after a meal.

The optimal amount per dose is 5 granules.

Consultation with a doctor is necessary to determine the potency, frequency, and duration of administration.

Adverse Reactions

None described to date.

Contraindications

  • Individual sensitivity to the drug;
  • Lactose intolerance.

Special Precautions

The dosage regimen and frequency of administration are determined by the doctor.

If there is no therapeutic effect within 3 days, or if adverse reactions occur, you should consult a doctor.

Overdose

No information on overdose cases has been received to date.

Drug Interactions

It is possible to use other medicines while being treated with Baryta carbonica.

Storage Conditions

At a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life is 5 years.

Dispensing Status

The drug is available without a prescription.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS